DE69231918D1 - Peptidantagonisten des bradykinin - Google Patents
Peptidantagonisten des bradykininInfo
- Publication number
- DE69231918D1 DE69231918D1 DE69231918T DE69231918T DE69231918D1 DE 69231918 D1 DE69231918 D1 DE 69231918D1 DE 69231918 T DE69231918 T DE 69231918T DE 69231918 T DE69231918 T DE 69231918T DE 69231918 D1 DE69231918 D1 DE 69231918D1
- Authority
- DE
- Germany
- Prior art keywords
- bradykinin
- antagonists
- produced
- analogs
- peptidantagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/18—Kallidins; Bradykinins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68795991A | 1991-04-19 | 1991-04-19 | |
US86624692A | 1992-04-14 | 1992-04-14 | |
PCT/US1992/003033 WO1992018156A1 (en) | 1991-04-19 | 1992-04-16 | Bradykinin antagonist peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69231918D1 true DE69231918D1 (de) | 2001-08-09 |
Family
ID=27104123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69231918T Expired - Lifetime DE69231918D1 (de) | 1991-04-19 | 1992-04-16 | Peptidantagonisten des bradykinin |
Country Status (11)
Country | Link |
---|---|
US (1) | US5385889A (de) |
EP (1) | EP0618810B1 (de) |
JP (1) | JPH07504155A (de) |
AT (1) | ATE202708T1 (de) |
AU (1) | AU1873992A (de) |
CA (1) | CA2106762C (de) |
DE (1) | DE69231918D1 (de) |
IE (1) | IE921296A1 (de) |
IL (1) | IL101648A (de) |
NZ (1) | NZ242446A (de) |
WO (1) | WO1992018156A1 (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5521158A (en) * | 1992-10-08 | 1996-05-28 | Scios Nova Inc. | Pseudopeptide bradykinin receptor antagonists |
US5541286A (en) * | 1992-10-08 | 1996-07-30 | Scios Nova Inc. | Bradykinin antagonist pseudopeptide derivatives of olefinic aminoalkanoic acids |
US5686565A (en) * | 1992-10-08 | 1997-11-11 | Scios Inc. | Bradykinin antagonist pseudopeptide derivatives of aminoalkanoic acids and related olefins |
WO1994019372A1 (en) * | 1993-02-17 | 1994-09-01 | Scios Nova Inc. | Cyclic bradykinin antagonist peptides |
EP0716661B1 (de) * | 1993-09-09 | 2000-04-05 | Scios Inc. | Pseudo-oder nicht peptidartige bradykinin rezeptor antagoniste |
US5817756A (en) * | 1993-09-09 | 1998-10-06 | Scios Inc. | Pseudo- and non-peptide bradykinin receptor antagonists |
DE4345062A1 (de) * | 1993-12-31 | 1995-07-13 | Hoechst Ag | Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Viruserkrankungen |
RU2180852C2 (ru) * | 1994-12-12 | 2002-03-27 | Омерос Медикл Системс, Инк. | Ингибирующий раствор и способ подавления боли, воспаления или спазма |
JPH10510540A (ja) * | 1994-12-12 | 1998-10-13 | オメロス メディカル システムズ,インコーポレーテッド | 灌注用溶液並びに疼痛、炎症及びけいれんの抑制法 |
WO1996039425A2 (en) * | 1995-06-05 | 1996-12-12 | Cortech, Inc. | Compounds having bradykinin antagonistic activity and mu-opioid agonistic activity |
US5891737A (en) * | 1995-06-07 | 1999-04-06 | Zymogenetics, Inc. | Combinatorial non-peptide libraries |
CA2221865C (en) * | 1995-06-09 | 2007-12-11 | The Regents Of The University Of Michigan | Bradykinin analogs as selective thrombin inhibitors |
DE19612067A1 (de) * | 1996-03-27 | 1997-10-02 | Hoechst Ag | Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen |
US7041785B1 (en) | 1996-08-19 | 2006-05-09 | UNIVERSITé DE SHERBROOKE | B1-bradykinin receptor antagonists and use thereof |
AU3935897A (en) * | 1996-08-19 | 1998-03-06 | Universite De Sherbrooke | B1-bradykinin receptor antagonists and use thereof |
US6982249B1 (en) | 1997-04-23 | 2006-01-03 | The Regents Of The University Of Michigan | Bradykinin analogs as selective inhibitors of cell activation |
US7659305B2 (en) * | 2002-10-31 | 2010-02-09 | Pfizer Inc. | Therapeutic proline derivatives |
GB0225379D0 (en) * | 2002-10-31 | 2002-12-11 | Pfizer Ltd | Therapeutic proline derivatives |
JP4631262B2 (ja) * | 2003-10-07 | 2011-02-16 | 東レ・ファインケミカル株式会社 | (シス)−4−ヒドロキシプロリン誘導体の製造方法 |
US7605120B2 (en) * | 2003-10-22 | 2009-10-20 | Amgen Inc. | Antagonists of the brandykinin B1 receptor |
JP2005350417A (ja) * | 2004-06-11 | 2005-12-22 | Dai Ichi Seiyaku Co Ltd | 還元的エーテル化法を用いたピロリジン誘導体の製造法 |
WO2008119005A1 (en) * | 2007-03-27 | 2008-10-02 | Trustees Of Tufts College | 3,4-dehydro-proline-containing inhibitors of dipeptidylpeptidase iv |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2964956D1 (en) * | 1978-07-18 | 1983-04-07 | Kabi Ab | Bradykinin inhibiting tripeptide derivatives, process for their preparation and pharmaceutical preparations containing them |
US4483850A (en) * | 1982-05-10 | 1984-11-20 | Merck & Co., Inc. | N-Terminal substituted oligopeptide converting enzyme inhibitors |
DE3303112A1 (de) * | 1983-01-31 | 1984-08-09 | Hoechst Ag, 6230 Frankfurt | Verfahren zur racemattrennung optisch aktiver bicyclischer imino-(alpha)-carbonsaeuren |
US4693993A (en) * | 1985-06-13 | 1987-09-15 | Stewart John M | Bradykinin antagonist peptides |
US4801613A (en) * | 1985-06-13 | 1989-01-31 | Nova Technology Limited Partnership | Bradykinin antagonist peptides |
US4912231A (en) * | 1987-06-15 | 1990-03-27 | E. R. Squibb & Sons, Inc. | Process for preparing (trans)-4-phenyl-L-proline derivatives |
US4923963A (en) * | 1987-09-02 | 1990-05-08 | Nova Technology Limited Partnership | Bradykinin antagonist peptides |
DE3820190A1 (de) * | 1988-06-14 | 1989-12-21 | Cassella Ag | Pyrrolderivate, ihre herstellung und ihre verwendung als pharmazeutische wirkstoffe |
IE63490B1 (en) * | 1988-11-24 | 1995-05-03 | Hoechst Ag | Peptides having bradykinin antagonist action |
DE3926822A1 (de) * | 1989-08-14 | 1991-02-21 | Hoechst Ag | Peptide mit bradykinin-antagonistischer wirkung |
US4937355A (en) * | 1989-01-17 | 1990-06-26 | E. R. Squibb & Sons, Inc. | Process for preparing (trans)-4-substituted-dl-proline derivatives |
WO1992018155A1 (en) * | 1991-04-19 | 1992-10-29 | Nova Technology Limited Partnership | Bradykinin type peptides |
-
1992
- 1992-04-16 JP JP4510290A patent/JPH07504155A/ja active Pending
- 1992-04-16 DE DE69231918T patent/DE69231918D1/de not_active Expired - Lifetime
- 1992-04-16 AU AU18739/92A patent/AU1873992A/en not_active Abandoned
- 1992-04-16 WO PCT/US1992/003033 patent/WO1992018156A1/en active IP Right Grant
- 1992-04-16 EP EP92917374A patent/EP0618810B1/de not_active Expired - Lifetime
- 1992-04-16 CA CA002106762A patent/CA2106762C/en not_active Expired - Lifetime
- 1992-04-16 AT AT92917374T patent/ATE202708T1/de not_active IP Right Cessation
- 1992-04-19 IL IL10164892A patent/IL101648A/en not_active IP Right Cessation
- 1992-04-22 IE IE129692A patent/IE921296A1/en not_active Application Discontinuation
- 1992-04-22 NZ NZ242446A patent/NZ242446A/en unknown
-
1993
- 1993-12-16 US US08/167,052 patent/US5385889A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0618810A1 (de) | 1994-10-12 |
WO1992018156A1 (en) | 1992-10-29 |
EP0618810B1 (de) | 2001-07-04 |
IL101648A0 (en) | 1992-12-30 |
JPH07504155A (ja) | 1995-05-11 |
EP0618810A4 (de) | 1994-12-07 |
CA2106762A1 (en) | 1992-10-20 |
IL101648A (en) | 1996-08-04 |
CA2106762C (en) | 2000-10-10 |
NZ242446A (en) | 1994-04-27 |
ATE202708T1 (de) | 2001-07-15 |
IE921296A1 (en) | 1992-10-21 |
US5385889A (en) | 1995-01-31 |
AU1873992A (en) | 1992-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE202708T1 (de) | Peptidantagonisten des bradykinin | |
EA199800563A1 (ru) | Антагонисты гормона, высвобождающего гонадотропин | |
ES2130265T3 (es) | Region de union al receptor de la toxina difterica. | |
DE69226708D1 (en) | Bradykinin typische peptide | |
ES2187958T3 (es) | Antagonistas de gnrh. | |
MX9204861A (es) | Analogos de polipeptidos que tienen actividad liberadora de la hormona de crecimiento. | |
EA199800559A1 (ru) | Антагонисты гонадотропин-высвобождающего фактора | |
EA199800564A1 (ru) | Антагонисты гонадотропин-высвобождающего фактора | |
NZ568769A (en) | Human monoclonal antibodies against CD20 | |
EA200300050A1 (ru) | Гликопептидфосфонатные производные | |
DE69925024D1 (de) | Verwendung von eph-rezeptor-antagonisten und agonisten zur behandlung von vaskulären krankheiten | |
DE69942753D1 (de) | Peptidantagonist von Zonulin und dessen Verwendung | |
DE69434181D1 (de) | Therapeutische Peptid Derivate | |
EA200300856A1 (ru) | Долгоживущие производные рилизинг-фактора гормона роста | |
EA200100780A1 (ru) | Антагонисты tweak и рецептора tweak и их использование для лечения иммунологических заболеваний | |
HUP0002704A2 (hu) | Az 5. és a 6. helyzetben módosított GnRH antagonisták | |
ES2123810T3 (es) | Heterociclos utiles como antagonistas de neuroquinina. | |
ES2150901T3 (es) | Antagonistas de hormonas del crecimiento. | |
EA200000198A1 (ru) | 2-ациламинопропанамины в качестве антагонистов рецепторов тахикининов | |
ES2061908T3 (es) | Antagonistas competitivos de gonadoliberina. | |
EA200000168A1 (ru) | Фармацевтическая композиция, снижающая продуцирование белка мср-1 | |
BR0207451A (pt) | Derivados de quinolina, isoquinolina e ftalazina como antagonistas do hormÈnio liberador de gonadotropina | |
ECSP972344A (es) | Proteinas antiobesidad |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |